Furthermore, SELENOP has been associated with severity of NAFLD in two cross-sectional studies involving patients in China and Italy (21, 22), however it should be noted that in some of these studies additional biomarkers of total selenium were not assessed, lacking thus a more comprehensive profile of selenium in NAFLD. The gene discussed is SELENOP; the disease is metabolic dysfunction-associated steatotic liver disease.